Semi-Annual Statement Of Income

Astellas Pharma Inc. - Filing #7258550

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income
Statement of income
Net sales
789,619,000,000 JPY
688,435,000,000 JPY
Cost of sales
116,419,000,000 JPY
114,688,000,000 JPY
Ordinary profit (loss)
431,119,000,000 JPY
373,257,000,000 JPY
Gross profit (loss)
673,200,000,000 JPY
573,746,000,000 JPY
Selling, general and administrative expenses
405,895,000,000 JPY
379,763,000,000 JPY
Extraordinary income
186,000,000 JPY
22,000,000 JPY
Extraordinary losses
69,135,000,000 JPY
40,189,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
267,305,000,000 JPY
193,984,000,000 JPY
Profit (loss) before income taxes
362,170,000,000 JPY
333,090,000,000 JPY
Non-operating income
193,090,000,000 JPY
192,636,000,000 JPY
Income taxes - current
40,765,000,000 JPY
38,435,000,000 JPY
Income taxes - deferred
1,686,000,000 JPY
2,494,000,000 JPY
Non-operating income
Income taxes
42,451,000,000 JPY
40,929,000,000 JPY
Non-operating expenses
29,276,000,000 JPY
13,363,000,000 JPY
Non-operating expenses
Interest expenses
12,322,000,000 JPY
10,188,000,000 JPY
Profit (loss)
JPY
JPY
JPY
319,719,000,000 JPY
319,719,000,000 JPY
JPY
319,719,000,000 JPY
JPY
JPY
JPY
319,719,000,000 JPY
JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
8,000,000 JPY
2,000,000 JPY
Extraordinary losses
Impairment losses
1,197,000,000 JPY
2,795,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.